The Eleven Fund is a venture capital firm with U.S. later-stage venture investment activity in healthcare, including biotechnology, life sciences and pharmaceutical therapeutics. It is relevant for founders in therapeutics and related life sciences sectors raising Series C or other later-stage venture rounds.